Adrenoleukodystrophy (ALD) is a demyelinating disease of the central nervous system that results from a genetic deficiency of ALDP, an ABC protein involved in the transport of very long-chain fatty acids (VLCFAs). The cloning of the ALD gene and the positive effects of allogeneic bone marrow transplantation support the feasibility of a gene therapy approach. We report the retroviral transfer of the ALD cDNA to peripheral blood and bone marrow CD34"'" cells from control donors and ALD patients. Prestimulation of these cells with cytokines, followed by infection with the M48-ALD retroviral vector, resulted in 20% transduction efficiency (4-40%) and expression of the vector-encoded ALDP in 20% of CD34+ cells (7.3-50%). Long-term culture (LTC) of transduced CD34+ cells from two ALD patients showed efficient transduction (24-28%) and stable expression (25-32%) of ALDP in derived clonogenic progenitors at 3 weeks of culture. The expression of ALDP in CFU cells derived from 5 and 6 weeks of LTC confirmed the effective transduction of LTC-initiating cells. Expression of ALDP was observed in CD68"'" CFU-derived cells, suggesting that monocytemacrophages, the target bone marrow cells in ALD, were produced from transduced progenitor cells. VL-CFA content was corrected in LTC and CFU-derived cells in proportion to the percentage of transduced cells, indicating that the vector-encoded ALDP was functional. Although not efficient yet to allow a clinical perspective, these results demonstrate the feasibility of ALD gene transfer into CD34"'" cells of ALD patients.
INTRODUCTION
X-LINKED ADRENOLEUKODYSTROPHY (ALD), 3 common neurodegenerative disorder affecting 1 in 20,000 males, is characterized by a progressive demyelination of the central nervous system (CNS) and by adrenal insufficiency (Moser et ai, 1995; Aubourg, 1996) . Phenotypic variation is frequent within the same kindred. Patients with the cerebral form of ALD remain apparentiy normal untd 5-12 years of age. Thereafter, progressive cerebral demyelmation leads to death within 3-5 years. The adult form (adrenomyeloneuropathy, AMN) affects the spinal cord of young adults and leads to severe paraplegia within 5-15 years. Addison's disease may be the only clinical manifestation of ALD. The mechanisms of such phenotypic variation are not known.
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All forms of ALD accumulate excessive amounts of very long-chain fatty acids (VLCFAs) in cerebral white matter, adrenal glands, fibroblasts, and plasma owing to an impairment of the ;8-oxidation of these fatty acids in peroxysomes (Moser et ai, 1995; Aubourg, 1996) . The ALD gene encodes a 75-kDa protein, named ALDP, which is a new member of the ATP-binding cassette (ABC) transporter famdy (Higgins, 1992; Mosser et ai, 1993) . ALDP is located in the peroxisomal membrane (Contreras et ai, 1994; Mosser et ai, 1994; Watkins et ai, 1995) and may transport the activated VLCFACoA esters into peroxisomes (Hettema et ai, 1996; Shani and Valle, 1996) .
A lipid diet (Lorenzo's oil) that normalizes plasma VLCFA widiin 2 montiis (Rizzo et ai, 1989; Aubourg et ai, 1993; Kaplan et ai, 1993) failed to modify neiu-ological deterioration in cerebral ALD or AMN. Attempts to use bone marrow transplantation (BMT) in the advanced stage of the disease were unsuccessful (Moser et ai, 1984; Yeager et ai, 1986) . Bone marrow transplantation was reevaluated in an 8-year-old boy who had early neurologic involvement. Two years after transplantation, the neuropsychological and neurologic deficits disappeared and the magnetic resonance imaging (MRI) scan normalized (Aubourg et ai, 1990) . Complete reversal of neurologic manifestations is still maintained 9 years later in this patient. Similar positive results were obtained in 28 other ALD patients provided that BMT is performed at an early stage of the disease (Shapiro et ai, 1997) .
The lack of histocompatible donors, however, limits the efficacy of allogeneic BMT, and the procedure remains associated with significant morbidity and mortality risks. We considered therefore that ALD gene transfer into autologous hematopoietic stem cells followed by transplantation would be a valuable therapeutic altemative.
We previously demonstrated that retroviral-mediated transfer of ALD cDNA is followed by appropriate targeting of the vector-encoded ALDP in peroxisome and restores VLCFA oxidation in ALD fibroblasts in vitro (Cartier et ai, 1995) . The present study reports the transfer of the human ALD cDNA into peripheral blood or bone marrow CD34"'" cells from control donors and ALD patients and expression of the vector-encoded ALDP in long-term bone marrow culture.
MATERIALS AND METHODS

Virus production
The vector M48-ALD, containing the full-length ALD cDNA under the control of the phosphoglycerate kinase (PGK) promoter, was constmcted and packaged as described (Cartier et ai, 1995) . The M48-ALD-producing cell line was grown in Dulbecco's moddied Eagle's medium (DMEM; GIBCO-BRL, Grand Island, NY) with 10% decomplemented newbom calf semm (GIBCO-BRL). Supematant from a high-titer ^-CRIP clone (determined by ALDP immunostaining of NIH 3T3 murine fibroblasts in a limiting dilution infection assay) was harvested 24 hr after a medium change on confluent monolayers and directiy used for infection. This producer was shown to be free of helper vims by a vims mobilization assay (Danos, 1991) .
Hematopoietic cells
Peripheral blood (PB) progenitor cells mobUized by chemotherapy and granulocyte colony-stimulatmg factor (G-CSF) and bone marrow (BM) cells from four conttol patients without ALD were obtained after informed consent. Bone marrow cells were collected from an autologous rescue sample from one ALD patient who underwent allogeneic bone marrow ttansplantation and from two ALD patients who provided bone marrow aspirates for diagnostic procedures (investigation of thrombocytopenia due to Lorenzo's oil) (Zinkham et ai, 1993) . Immunocytochemistry and Westem blotting demonsttated a complete absence of ALDP in fibroblasts and/or mononuclear cells from these ALD patients (Feigenbaum et ai, 1996) .
CD34'^ cell enrichment
Light-density mononuclear cells (MNCs) were obtained by centrifugation on a Diatrizoate-FicoU gradient (Feigenbaum et ai, 1996) . A total of 0.6-1 X 10' nucleated BM or PB cells from the sources described above were incubated at room temperature with the anti-CD34 monoclonal antibody 12-8 IgM (CellPro, Bothell, WA) and passed through an avidin-biotin immunoadsorption column (CEPRATE; CellPro) according to the manufacturer recommendations. Ninety-one to 94% of cells purified from PB and 71-85% of cells purified from BM were shown to be CD34"'' by flow cytometric analysis. Cells were divided into aliquots of 4-6 X 10* cells that were either cryopreserved using standard procedures in 10% dimethyl sulfoxide (DMSO) until subsequent transduction experiments or placed directly into stimulation medium.
Flow cytometric analysis
Cell siuface antigens were detected using mouse anti-human CD34 monoclonal antibody (HPCA-2; Becton Dickinson, San lose, CA) and mouse anti-human CD45 monoclonal antibody (Becton Dickinson) conjugated to fluorescein isotiiiocyanate (FFTC) or phycoerydirin (PE). Isotype conttols were FTTC-or PElabeled mouse immunoglobulins (IgGi; Becton Dickinson). Five to 10 X 10* cells were incubated at 4°C for 20 min in 0.1 ml of phosphate-buffered salme (PBS) with 1% bovme serum albumin and 2 /xl of die undUuted antibodies. After washing twice m icecold PBS contaming 0.01% sodium azide, cells were analyzed on a Coulter (Hialeah, FL) Epics Profile n flow cytometer.
Prestimulation and transduction of CD34'^ cells CD34+-enriched cells were placed in DMEM widi 10% newbom calf semm (GIBCO-BRL), recombinant human interleukin 3 (rhIL-3; 10 ng/ml), rhIL-6 (10 ng/ml), recombinant human stem cell factor (rhSCF, 50 ng/ml) (Pepro Tech, Canton, MA) at a density of 10^ cells/ml. The cells were placed in T-25 flasks and incubated at 37°C with 5% CO2 for 16 hr.
Stimulated CD34+-enriched cells were ttansduced by addition of cell-free vims-containmg supematant (5 X 10"* CD34+ cells/ml) supplemented with rhIL-3, rhIL-6, rhSCF in the presence of Polybrene (8 /ag/ml) (Sigma, St. Louis, MO). Fresh supematant and cytokines were replaced four to five times in 30 hr (see Resuhs). Twelve hours after the addition of the last vmiscontaining supematant, cells were removed, centrifuged, and then dkectiy analyzed or plated for long-term culture (LTC).
Long-term culture
Infected and noninfected CD34+ cells (2.5 X lO'* cells/ml) were seeded in 24-well plates on irradiated (1000 rads) preestablished allogeneic sttomal layers in long-term bone marrow cell (LTBMC) premixed medium (MyeloCult; Stem Cell Technologies, Vancouver, British Columbia, Canada). Cells were incubated at 33°C, in 5% CO2. Half of the medium and nonadherent cells were removed each week and fresh medium was added (Sutheriand and Eaves, 1994) . Cultures were terminated at 1, 3, 5 and 6 weeks; nonadherent cells were removed, washed in PBS, and directly analyzed by immunocytochemistry or plated in a standard CFU-GM assay.
Colony-forming unit granulocyte-macrophage assay CFU-GM assays were performed essentially as described (Sudieriand and Eaves, 1994) . Nonadherent cells from die LTC were plated in tiiplicate at 10* to 5 X 10"* cells/ml of ready-mix mediylcellulose (MedioCult; Stem Cell Technologies) in 35-mm plates and mcubated at 37°C in 5% CO2. Colonies (widi more dian 50 cells) were scored 15 and 21 days later according to morphology as CFU-G, -M, and -GM. Individual colonies were isolated for subsequent polymerase chain reaction (PCR) assay and pooled colonies were analyzed by immunocytofluorescence.
Polymerase chain reaction and Southern blot DNA from uninfected and infected CD34+ and LTC cells (2 X 10^) was dkecdy exttacted on Qiagen columns (Qiagen, Chatsworth, CA) and resuspended in 400 pi of Tris-HCl, 10 mM (pH 9).
Colonies grown in methylcellulose were individually picked, washed in PBS, and incubated for cell lysis in 30 pi of Tween 20-0.45% proteinase K (6 ^ig/ml) at 56 and 90°C for two 10-min periods.
PCR was performed on a Perkin-Elmer (Norwalk, CT) 2400 thermocycler using a primer pair designed specifically to detect vector provims DNA, die 5' (sense) primer (5'-AAGTTCGA-GAAGCTGGACTCAGCT-3') located in the 3' end of die ALD cDNA (nucleotides [nt] 2424-2447) (Mosser et al, 1993) and the 3' (antisense) primer (5'-GACCACTGATATCCTGTCTT-TAAC-3') m die 3' long terminal repeat (LTR) region of die Moloney murine leukemia vims (Mo-MuLV) vector backbone. PCR reactions were performed m buffer containing 10 mM Tris (pH 8.3), 50 mM KCl, 1.5 mM MgCl2 witii 10-/u,l DNA samples, 1.25 U of Taq DNA polymerase (Perkm-Elmer), 20 pmol of the two primers, 10 mmol of each dNTP (Phaimacia, Uppsala, Sweden) in a fmal volume of 50 pi. Amplification conditions mcluded initial denatiu-ation at 94°C for 5 mm foUowed by 35 cycles of 94°C for 30 sec, 64°C for 30 sec, and 72°C for 45 sec and a fmal elongation at 72°C for 10 min. To standardize DNA concenttations in die above-described PCR assay, conttol amplification was performed widi two primers located in exon 1 (nt 466-483 and 702-721) of die ALD gene (5'-ATGGAGCC-CA-CAAAGTCT-3' and 5'-GCCACATACACCGA-CAGGAA-3'), using die same conditions except diat die reaction was supplemented widi 5% DMSO and die annealing temperamre was 58°C.
For semiquantitative PCR assay, a vector copy number per cell standard curve was established: different DNA dilutions of a ^-CRIP clone carrying one copy per genome of M48-ALD provims in 3T3 cell DNA were amplified with specific provims primers. To standardize the amount of DNA used in PCR assay of provims integration, we adjusted the quantity of DNA to obtain equivalent signal intensity of ALD exon 1 amplification product in all samples and in the •^I'-CRIP reference ceUs.
After exttaction and amplification, DNA products were separated on 1% agarose gels, blotted onto Hybond N+ (Amersham, Arlington Heights, IL) membranes, and hybridized to a [a-32p]dCTP (Amersham) M48-ALD or ALD exon 1 probe (Ready Prime; Amersham). Membranes were washed with 0.1 SSC/0.1 SDS buffer (IX SSC is 0.15 M NaCl plus 0.015 M sodium cittate; SDS, sodium dodecyl sulfate) at 42°C for 20 min, at 50°C for 20 min, and at 70°C for 10 min and exposed to Hyperfilm MP (Amersham) for 2 hr at room temperature.
Images of Southem blot fdters were recorded on an Imager (Appligene-Oncor) and the intensity of each signal was scanned and quantified with the public domain NIH image program. The percentage of cells showing provims integration was calculated on the basis that positively transduced cells contained one copy per genome of the provims. For every assay, samples of DNA exttacted from uninfected cells were tested in parallel to detect contamination of reagents with PCR product.
Immunocytochemistry
Cells were centrifuged at 100 X g for 10 min as described (Feigenbaum et ai, 1996) . The mouse anti-human ALDP monoclonal antibody (MAb 1D6) has been previously characterized (Mosser et ai, 1994) . Labeling of ALDP was revealed with anti-mouse antibodies directiy conjugated to Cy3 (Jackson ImmunoResearch, Westgrove, PA) (Cartier et ai, 1995) . The percentage of ALDP-positive cells was calculated by counting an average of about 200 cells on each slide. Results were expressed as the mean value of two counts made blindly by two investigators.
For ALDP and catalase colocalization experiments, cells were first tteated with MAb 1D6 and rabbit anti-human catalase polyclonal antibody (Cbemicon, Temecula, CA). Cells were further incubated with donkey anti-mouse IgG (H -i-L) antibody directiy conjugated to Cy3 and goat anti-rabbit IgG (H -f L) antibody directiy conjugated to fluorescein (Vector Laboratories, Burlingame, CA).
Expression of ALDP in monocytes derived from pooled CFU colonies was analyzed usmg double immunostaining with anti-ALDP and anti-CD68 antibodies (Pulford et ai, 1989) . Cells were first tteated with a rabbit anti-human ALDP polyclonal antibody (1693) and a mouse anti-human CD68 KPl monoclonal antibody (Dako, Carpinteria, CA), then further incubated with horse anti-mouse IgG (H -I-L) antibody directiy conjugated to fluorescein (Vector Laboratories) and anti-rabbit (H -I-L) IgG antibody directiy conjugated to Cy3 (Cbemicon). A mouse MsIgGi isotype antibody (Coulter) was used as a conttol.
The anti-human ALDP polyclonal antibody (1693) was obtained by immunization of two rabbits with a synthetic peptide as described (Fouquet etai, 1997) . This synthetic peptide comprises the last 19 carboxy-terminal amino acids of human ALDP (Mosser et ai, 1993) . The 1693 polyclonal antibody does not cross-react with the 70-kDa peroxisomal membrane protein (PMP) (Kamijo et ai, 1990 ) and the ALD-related protein (Lombard-Platet et ai, 1996).
Appropriate filters for each fluorochrome, and a combined filter for fluorescein and Cy3, were used on a light microscope equipped for fluorescence (Nikon Optiphot-2).
Measurement of very long-chain fatty acids in longterm culture-and CFU-derived cells V-ferr-Butyldimethylsilyl-V-methyltrifluoroacetamide (MTBSTFA) widi 1% terf-butyldimethyl-chlorosdane (TB-DMCS) was purchased from Fluka (Buchs, Switzeriand). [3,3,5,5-2H4]docosanoic (C22:o-d4) and [3,3,5,5-2H4] hexacosanoic (C26:0-d4) acids were a gift from H.J. ten Brink (Amsterdam, The Nedierlands). Natural docosanoic (C22:o) and hexacosanoic (C26:o) acids were obtained from Sigma.
Cells (5 X 10^) were suspended m 200 pi of twice-distdled water, sonicated, and added to 2 ml of chloroform-methanol (1:1; v/v) containing 100 pM C22:o-d4 and 25 pM C26:0-d4 (intemal standards) that had been evaporated to dryness. After evaporation to dryness, the pellet was resuspended in 2 ml of acetonitrile with 400 pi of hydrochloric acid (12 M), heated for 1 hr at 110°C, and exttacted twice with 5 ml of hexane after cooling. Hexane phases were pooled, ttansferred into vials, and evaporated to dryness. The butyldimethylsilyl (TBDMS) derivatives of fatty acids were obtained by dissolving the residues in 20 pi of pyridme-(MTBSTFA/MTDMCS; 99:1) (1:1, v/v) and heatmg at 60°C for 10 mm. Samples were stored at -20°C until analysis.
To establish a calibration curve, variable amounts of natural C22:0 (0 to 100 pmol) and C26:o (0 to 7.5 pmol) were mixed and added to C22:o-d4 (100 pmol/liter) and C26:0-d4 (25 pmol/liter) as intemal standards. After exttaction, the fatty acid mixture was converted into TBDMS derivatives.
TBDMS derivatives of fatty acids were separated on a gas chromatograph (Varian 3400, Sunnyvale, CA) coupled with a quadrapolar mass specttometer (Incos XL-50; Finnigan MAT, San Jose, CA). Chromatographic conditions were as follows: after an initial isotherm of 1 min at 80°C and purge split at 1 min, the temperature was programmed from 80 to 290°C (15°C/min) and from 290 to 340°C (3°C/min) on a BPX-5 capillary column (5% phenyl polysiloxane; 30 m X 0.33 mm; film thickness, 0.25 pm; Scientific Glass Engineering, Melbourne, Austtalia). Ions at m/z 397, m/z 401, mIz 453, and m/z 457, corresponding to the [M-57] ions of 22:0, 22:0-d4, 26:0, and 26:0-d4 TBDMS derivatives, were selectively monitored using electton impact. The correspondmg peaks were integrated and the content of C22:o and C26:0 fatty acids was calculated according to the calibration curve using C22-d4 and C26-d4 as intemal standards. Results were expressed as C26:o/C22:o ratios.
RESULTS
Retroviral transduction of ALD cDNA in control CD34-^ cells
We first evaluated transduction efficiency of M4B-ALD rettoviral vector in CD34+ cells from four control individuals.
The efficiency of transduction was determmed by measuring, widi a senuquantitative PCR assay, flie percentage of cells containing the M48-ALD provims and by studymg, wifli immunocytochemisfry, the percentage of cells expressing recombinant ALDP. Immunocytofluorescence analysis with MAb 1D6 of conttol unttansduced CD34+ cells, stunulated or not by cytokines, revealed consistentiy a weak punctate fluorescence signal suggestmg a low expression of ALDP (Fig. 1A and B, artowheads) . We previously demonsttated by Westem blot analysis diat ttansduction with M48-ALD vector mcreased die expression of ALDP m normal or ALD fibroblasts by fivefold (Cartier et ai, 1995) . This mcrease was cortelated widi higher expression of ALDP ui fibroblasts, using immunocytochemistry (see Fig. 3 in Cartier et ai, 1995) . We observed simUar overexpression of ALDP m ttansduced normal CD34+ cells (compare the expression of ALDP in nonttansduced normal CD34'^ cells [ Fig. 1A and B , arrowheads] and in ttansduced CD34+ cells [Fig. IB, arrow] ).
Preliminary smdies using 10^ cells/ml and one to diree infection cycles led to low provims integration (<2%) (Fig. 2 , lane *) and expression of recombmant ALDP in less than 10% of ttansduced cells (data not shown). When cells were plated at 5 X 10''/ml rettoviral supematant and submitted to four or five cycles of 6-hr infection, 25% of the PB or BM cells showed M48-ALD provims integration (Table 1 and Fig. 2 ). Immunocytofluorescence showed that 22 to 25% of these cells overexpressed ALDP (Table 1 and Fig. IB ).
Retroviral transduction of ALD cDNA in BM CD34~^ cells of ALD patients These optimized ttansduction conditions were used to infect BM CD34+ cells of three ALD patients. Two CD34+ aliquots from two ALD patients and three CD34"'" aliquots from the third patient were ttansduced in a total of seven experiments. Transduction efficiency was similar to that observed with PB or BM conttol CD34+ cells (Table 1) . Semiquantitative PCR assay demonsttated that 20% of ttansduced cells (calculated as a median of the seven experiments, range, 4-40%) integrated the M48-ALD provims (Table 1, Fig. 2 ). After ttansduction, a marked punctate fluorescent staining was detected in CD34"'" cells of the three ALD patients as compared with uninfected cells (Fig. IC and D) . Colocalization smdies wifli anti-catalase antibody confmned that flie localization of recombinant ALDP was peroxisomal (data not shown). The absence of cytosolic aggregates in the ttansduced ALD CD34+ cells mdicated diat most, if not all, recombinant ALDP had been correcdy incorporated into peroxisomal membrane. Expression of vectorencoded ALDP correlated widi die percentage of M48-ALDP provims uitegration (Table 1) . While no BM CD34+ cells of die three ALD patients expressed ALDP before ttansduction, a median 20% (range, 7.3-50%) of cells expressed ALDP after five cycles of infection at 5 X 10^ cells/ml supematant (Table 1) .
Transduction of long-term culture initiating cells from BM CD34+ cells of ALD patients
To determine whetiier CD34+ cells of ALD patients could be used as potential targets for gene ttansfer into hematopoietic progenitors, ttansduced and nonttansduced BM CD34+ cells of two ALD patients were maintained in LTC for 5 weeks (patient 1, experiment 1) and 6 weeks (patient 2, experunent 2). At different time points, infected and uninfected cells were collected for assessment of clonogenic potential and gene ttansfer efficiency. The clonogenic potential of ALD BM cells (determined on CFU-G, -M, and -GM count) was identical in infected and uninfected cells (data not shown). Gene ttansfer efficiency was evaluated by die presence of M48-ALD provims on cells derived from CFU-GM assays and by the expression of ALDP on cells dtiectiy collected from the LTC.
The analysis of clonogenic progenitors (CFU-M and -GM) obtained immediately after infection showed M48-ALD proviral integration in 32% (experiment 1) and 18% (experiment 2) of ALD cells (Table 2) . These percentages remained stable at 3 weeks of culture (28 and 24%) ( Table 2 and Fig. 3) . Expression of the transduced ALD cDNA was analyzed by immunocytofluorescence on cells directly harvested from the LTC. Less than 5% of ALDP-positive cells was found in the conttol uninfected culmre (Table 2) (experiment 2) of transduced ALD cells expressed ALDP on day 0 of the LTC, 25% (experiment 1) and 32% (experiment 2) still expressed ALDP on day 23 (Fig. IE) . This resuti was correlated with the percentage of proviral integration in the CFU-M and -GM colonies (Table 2) . A decrease in ALDP expression to 3% was observed in cells directly coUected from the LTC in experiment 1 at 5 weeks; this was correlated with the decrease in the percentage of M48-ALD provims integration in the CFU assay (6%) ( Table 2 ). This result contrasted with the stability of ALDP expression observed in ALD cells derived from the LTC in the second experiment. Twenty percent of these cells expressed ALDP on day 0, whereas 22.5 and 17.6% expressed ALDP at 5 and 6 weeks of culture (Table 2 and 2 ''Long-term cultures were initiated from transduced and nontransduced CD34+ BM cells of two ALD patients. Cells were harvested on day 0 (experiments 1 and 2), day 10 (experiment 1), days 23 and 35 (experiments 1 and 2), and day 42 (experiment 2) after infection. Nonadherent cells were assayed in a standard CFU-GM assay. Individual CFU-GM colonies were picked and tested for M48-ALD provims integration. PCR^ CFU columns indicate the percentage of PCR-positive colonies showing the presence of M48-ALD provims (the number of colonies analyzed at each point is also shown). Cells were also directly harvested from the LTC and analyzed for ALDP expression by immunocytochemistry. IF^ cells columns indicate the percentage of ceUs, harvested from the LTC at each time point, expressing the vector-encoded ALDP.
Abbreviation: ND, Not determined.
periment 1) and 6 weeks (experiment 2) of LTC, respectively, 2 and 6.1% of the pooled CFU-GM cells from the clonogenic assay still expressed vector-encoded ALDP (Table 3 and Fig.  4) . Together with the demonstration of M48-ALD proviral integration in 5-week LTC-derived colonies, these results demonsttate that LTC-initiating cells were transduced. Expression of recombinant ALDP was analyzed in CD68^ cells derived from pooled CFU colonies. Anti-CD68 KPl antibody sttongly stains monocytes and macrophages, while granulocytes are weakly or negatively labeled (Pulford et ai, 1989) . Most CFU-derived cells pooled from methylcellulose at 42 days of LTC were CD68''", whereas few cells were negative or weakly marked (Fig. 4B) . Expression of recombinant ALDP in CD68+ ALD cells derived from the CFU assay at 42 days of the LTC demonstrates that progenitor-derived monocytemacrophages were transduced by the M48-ALD vector (Fig. 4) . ^The C26:o/C22:0 ratio is given as the mean ± SD of three determinations of the number (AO of studied samples.
•The expected C26:o/C22:o ratio is calculated by linear regression for the fraction (given in percentage ui parentheses) of LTC-or CFU-derived cells expressing vector-encoded ALDP, as detected by hnmunocytofluorescence.
assay allowed us to calculate the expected C26:o/C22:0 values of transduced ALD cells by simple linear regression (see Table 4 ).
To evaluate the cortection of VLCFA metabolism after M48-ALD infection, die C26:o/C22:0 ratio was measured in ALD LTCand CFU-derived cells. Table 4 shows that the C26:o/C22:o ratio of unttansduced LTC cells from ALD patient (experiment 1) is flireefold that of normal LTC cells. Following infection with M48-ALD vector, we observed a small but consistent decrease in the C26:o/C22:o ratio in the ttansduced ALD cells at 0, 10, and 23 days of long-term culture. The conection of die C26:o/C22:0 ratio was slightiy greater than expected after normalization of the C26:o/C22:0 ratio with respect to the number of cells expressing vector-encoded ALDP, as determined by immunofluorescence (Table 4) . Overexpression of ALDP most Idcely increases the import of VLCFAs in peroxisomes of ttansduced cells and leads to an increased degradation of these fatty acids in LTC-or CFU-derived cells. A simdar observation has been made in transfected (K. Smith, personal communication, 1997) or ttansduced (our own observations, 1997) ALD fibroblasts. Altogedier, these results indicate that the vectorencoded ALDP localized in peroxisomes of LTC or CFU ALD cells is functional and can restore VLCFA metabolism.
DISCUSSION
The characteristic lesions of ALD consist of diffuse demyelination and marked loss of oligodendrocytes (Schaumburg et ai, 1975) . There is, however, indkect evidence that dysfunction of microglia, which comprise 10-20% of all glial cells and resemble macrophages (Peny and Gordon, 1991; Altman, 1994) , may affect oligodendrocytes of ALD patients. Wifliin die centtal nervous system, microglia are die predominant cell type expressmg die ALD protein (Fouquet et ai, 1997) . In addition, predominant microglial activation is constantly observed in the cerebral demyelinating lesions (Powers et ai, 1992) . The importance of microglial dysfunction in ALD is also supported by the observation that bone martow ttansplantation can reverse demyelination in ALD patients (Aubourg et ai, 1990; Krivit et ai, 1995a,b; Shapiro et ai, 1995 Shapiro et ai, , 1997 . Although the origm of microglia is still debated, it is generally considered that microglial cells derive from hematopoietic precursors (Hickey et ai, 1992; Lassman and Hickey 1993; Lassman et ai, 1993; Ling and Wong, 1993; Perry et ai, 1993) . The improvement of demyelinating lesions after heterologous BMT is possibly due to the replacement of abnormal microglia by normal hematopoietic donor-derived cells (Krivit et ai, 1995b) . In normal mice, up to 20% of microglia can be replaced by ttansplanted syngeneic bone manow cells expressing the human glucocerebrosidase gene from a rettoviral vector (Krall et ai, 1994) . These findings support a gene therapy approach based on the ex vivo ttansfer of the ALD gene into hematopoietic stem cells followed by autologous ttansplantation.
A recombinant rettoviral vector carrying the human ALD cDNA was used to ttansduce CD34''" cells purified from bone manow of ALD patients in the presence of IL-3, IL-6, and SCF (Dick et ai, 1991; Crooks and Kohn, 1993; Nolta et ai, 1995; Xu et ai, 1995) . Our results with the M48-ALD rettoviral vector are comparable to those reported using cell-free vims in the absence of sttomal support (Moore et ai, 1992; Nimgaonkar et ai, 1994; Ward et ai, 1994; Nolta et ai, 1995; Xu et ai, 1995; Fakbakn et ai, 1996) . Proviral integration in CFU at 5 weeks of LTC and expression of vector-encoded ALDP in CFUderived cells at 6 weeks of LTC suggest that LTC-initiating cells were ttansduced (Sutherland et ai, 1990; Sutherland and Eaves, 1994) . The expression of vector-encoded ALDP in CD68''" ALD cells derived from the CFU assay demonsttated that cells from the monocytic lineage, the target BM cell pop-ulation in ALD, were ttansduced. Fmally, VLCFA metabolism was corrected in LTC-and CFU-derived cells, indicating that flie vector-encoded ALDP was functional in these cells.
These preliminary results are encouraging but still far from allowing a phase I trial in ALD patients. Our results indicate diat approxunately 50 to 60% of ALD CD34+ cells would need to be conected to normalize the VLCFA concentration. As highlightened by clinical trials, the success of rettovttal gene therapy using hematopoietic precursors remains sttongly limited by the efficiency oiex vivo ttansduction of hematopoietic stem cells (Bordignon ef a/., 1995; Dunbar ef a/., 1995; Kohn etai, 1995) . Two conditions may improve the efficiency of the procedure: (1) bone marrow ablation followed by reconstitution with ttansduced cells, and/or (2) a selective in vivo growth advantage conferred to ttansduced cells by the therapeutic gene, as in the case of adenosine deaminase deficiency (Bordignon et ai, 1995; Kohn et ai, 1995) . In our smdy, we did not observe that normal or ALD-corrected cells had a survival advantage relative to ALD-deficient cells in vivo and in vitro. Accordingly, the smdy of ALDP expression in lymphocytes or culmred fibroblasts of heterozygous ALD women does not show skewed X inactivation favoring the normal allele (Watkiss et ai, 1993; Feigenbaum et ai, 1996) . We are now attempting to select ALD-ttansduced cells by using a bicisttonic constmct containing the multidmg resistance (MDR) gene (Medin et ai, 1996; Sokolic et ai, 1996; Ward et ai, 1994) . Preselection of MDR-expressing cells prior to marrow reconstitution by fluorescence-activated cell sorting using an antibody to extemal epitope of MDR could increase the number of ALD-expressing microglial cells in the brain. Altematively, optimization of the viral titer through the use of the vesicular stomatitis vims G envelope protein might allow better ttansduction rates of hematopoietic stem cells (Agrawal et ai, 1996; Ory et ai, 1996) . In fact, the need to target nondividing cells remains today the main limitation of rettoviral gene transfer into hematopoietic stem cells. Studies have shown that both adeno-associated vims (Zhou et ai, 1994) and rettovhal vectors modified with lentiviras components (Naldini et ai, 1996) are able to infect nondividing cells. These vectors might be useful for human use, once large-scale production and safety problems are solved.
